摘要
干眼是准分子激光原位角膜磨镶术(LASIK)后最常见的并发症之一。术前患者存在的眼表疾病和干眼状态是增加或加重术后干眼发生率的主要因素。本文综述LASIK术后干眼的药物治疗进展。
Dry eye is one of the most common complications after Laser in situ keratomileusis （LASIK）. Preoperative inflammation and dry eye condition are major risk factors for severe dry eye after LASIK. This review describes the progress in drug therapy for dry eye after LASIK.
出处
《世界临床药物》
CAS
2012年第1期45-49,共5页
World Clinical Drug
